Literature DB >> 6609855

Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitus.

K S Zier, M M Leo, R S Spielman, L Baker.   

Abstract

Synthesis of interleukin-2 (IL-2) by lymphocytes from 26 insulin-dependent diabetic subjects (IDDM) was compared with that by lymphocytes from 24 nondiabetic control subjects. The control group produced 1.001 +/- 0.071 U/ml (mean +/- SEM). The IDDM group, containing patients diagnosed between 5 days and 10 yr before testing, produced only 0.59 +/- 0.050 U/ml (P less than 0.002). IL-2 synthesis by 6 non-insulin-dependent diabetic subjects (NIDDM) was not decreased (mean +/- SEM, 1.20 +/- 0.04 U/ml). Moreover, decreased levels of IL-2 production was found with lymphocytes of patients in good control, as well as those in poor control. These data suggest that decreased IL-2 synthesis is specific for IDDM, not explainable solely as a consequence of poor metabolic control, and thus, might be involved in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609855     DOI: 10.2337/diab.33.6.552

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  34 in total

1.  An efficient hierarchical generalized linear mixed model for pathway analysis of genome-wide association studies.

Authors:  Lily Wang; Peilin Jia; Russell D Wolfinger; Xi Chen; Britney L Grayson; Thomas M Aune; Zhongming Zhao
Journal:  Bioinformatics       Date:  2011-01-25       Impact factor: 6.937

Review 2.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

3.  Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.

Authors:  M P Nair; E W Lewis; S A Schwartz
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

4.  Suppression of concanavalin A-induced responses in splenic lymphocytes by activated macrophages in the non-obese diabetic mouse.

Authors:  K Yokono; Y Kawase; M Nagata; N Hatamori; S Baba
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

5.  Defective autologous mixed leukocyte reaction in newly diagnosed type 1 diabetes mellitus.

Authors:  L Räsänen; H Hyöty; M Lehto; O P Kallioniemi; J Antonen; T Huupponen; J Karjalainen; P Leinikki
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

6.  The effect of zinc status on the immune function of diabetic rats.

Authors:  A D Mooradian; D C Norman; J E Morley
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

7.  Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans.

Authors:  T Mandrup-Poulsen; K Bendtzen; J Nerup; C A Dinarello; M Svenson; J H Nielsen
Journal:  Diabetologia       Date:  1986-01       Impact factor: 10.122

8.  Modulation of the IL-2 production defect in vitro in Graves' disease.

Authors:  Z Eisenstein; E Engelsman; M Weiss; Y Kalechman; B Sredni
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

9.  Antidiabetic effects of interleukin 1.

Authors:  A del Rey; H Besedovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

10.  Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis: antigen expression defect in vitro.

Authors:  C Giordano; R De Maria; M Todaro; G Stassi; A Mattina; P Richiusa; G Galluzzo; F Pantó; A Galluzzo
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.